Drug profile · INN
orphenadrine citrate
ORPHENADRINE CITRATE
orphenadrine citrate (ORPHENADRINE CITRATE) is a norepinephrine transporter inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — orphenadrine citrate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
orphenadrine citrate (ORPHENADRINE CITRATE) is a norepinephrine transporter inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Norepinephrine transporter inhibitor
Primary target: Glutamate [NMDA] receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is orphenadrine citrate?
orphenadrine citrate (ORPHENADRINE CITRATE) is a norepinephrine transporter inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for orphenadrine citrate?
ORPHENADRINE CITRATE is a marketed brand name for orphenadrine citrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of orphenadrine citrate?
orphenadrine citrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.